Kalorama on Fox Business News: The Business of Vaccines

Kalorama on Fox Business News: The Business of Vaccines

How big is the business of vaccines?  Yesterday, Fox Business News featured information from Kalorama’s global vaccine report.   They reported our estimate of the market at 25.5 billion in 2014.  Most of that is childhood vaccines, though influenza is also a large category.   But as Fox Business News pointed out, it’s not as profitable as the rest of the pharmaceutical market.  Vaccines are expensive to make, facilities are expensive and outsourcers can often be at capacity in peak seasons.   Thus there are just a few competitors that really compete in the market - Merck, Sanofi, Pfizer, Glaxo and Novartis.  Payers are governments with high volume negotiating power.  There is some innovation on the new vaccine or the delivery front but in terms of most vaccines sold for pediatric use or adult use 88% of the market is controlled by these companies. 

Video segment is here http://video.foxbusiness.com/v/4043746143001/the-big-business-of-vaccines/?#sp=show-clips